PAUL GAZZARA: Open Payments
NPI 1366417677 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 11 payments from 9 companies in 2025. Trend: 2023 $638 · 2024 $305 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Agios Pharmaceuticals, Inc. | 1 | $30 |
| Exact Sciences Corporation | 1 | $25 |
| PFIZER INC. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Indivior Inc. | 1 | $15 |
Products named: BREZTRI, PYRUKYND, Cologuard Collection Kit, ELIQUIS, SPRAVATO, ABILIFY ASIMTUFII, NUCALA, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
